ArticleNeuro-oncology advances

EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand.

Youri Hoogstrate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.